JPH07227284A - Method for treating synthetic dna - Google Patents
Method for treating synthetic dnaInfo
- Publication number
- JPH07227284A JPH07227284A JP4185794A JP4185794A JPH07227284A JP H07227284 A JPH07227284 A JP H07227284A JP 4185794 A JP4185794 A JP 4185794A JP 4185794 A JP4185794 A JP 4185794A JP H07227284 A JPH07227284 A JP H07227284A
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- container
- carrier
- solution
- adsorbed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【0001】[0001]
【産業上の利用分野】この発明はオリゴヌクレオチドを
レジンから切り離して回収するための合成DNAの処理
方法に関する。TECHNICAL FIELD The present invention relates to a method for treating synthetic DNA for recovering an oligonucleotide by cleaving it from a resin.
【0002】[0002]
【従来の技術】この種の合成DNAの処理方法として、
合成DNAにアンモニア水を加えて、レジンから「保護
されたオリゴヌクレオチド」を切り離す第1工程と、脱
保護されたDNA溶液を水で希釈して、この希釈液を多
数の担体が入った容器内に通し、該担体にオリゴヌクレ
オチドを吸着保持させる第2工程と、前記容器内に洗浄
液を通して不純物を除去する第3工程と、前記容器内に
酸性液を通してオリゴヌクレオチドのDMT基を外す第
4工程と、前記容器内に洗浄水を通して前記酸性液を除
去する第5工程と、前記容器に有機溶媒液を通し、該容
器内の前記担体からオリゴヌクレオチドを溶出させて回
収する第6工程とを経て、オリゴヌクレオチドを回収す
ることが公知である。2. Description of the Related Art As a method for treating this kind of synthetic DNA,
Ammonia water is added to the synthetic DNA to separate the "protected oligonucleotide" from the resin, and the deprotected DNA solution is diluted with water, and the diluted solution is placed in a container containing many carriers. Through a second step of adsorbing and holding the oligonucleotide on the carrier, a third step of removing impurities by passing a washing solution into the container, and a fourth step of removing an DMT group of the oligonucleotide by passing an acidic solution into the container. , Through a fifth step of removing the acidic liquid by passing wash water through the container, and a sixth step of passing an organic solvent liquid through the container and eluting and collecting the oligonucleotide from the carrier in the container, It is known to recover oligonucleotides.
【0003】[0003]
【発明が解決しようとする課題】問題は第2工程にあ
る。第1工程で得たDNA溶液に水を加えて希釈し、こ
の希釈液を前記容器に通したとき、該容器内にある多孔
性の担体にオリゴヌクレオチドが吸着保持されないまま
通過液に含まれて容器外に排出されることがある。そう
なると、第3工程以下の処理は全てが無駄な作業にな
る。しかも、最終的に精製された状態では目視で確認す
らできない状態下にあり、気付くのが遅れるところに問
題があった。その不手際を防ぐためには、次善策として
第2工程での通過液を最後まで保存しておき、第2工程
から再びやり直すことが考えられる。しかし、これも大
いなる無駄である。そこで本発明の目的は、第2工程を
経て第3工程に移る前に、前記容器中の担体にオリゴヌ
クレオチドが吸着保持されているか否かを、簡単な方法
でしかし確実に確認できるようにし、以て従来の処理作
業の無駄を無くせる合成DNAの処理方法を提供するに
ある。The problem lies in the second step. When the DNA solution obtained in the first step is diluted by adding water and the diluted solution is passed through the container, the porous carrier in the container contains the oligonucleotide without being adsorbed and retained in the passing solution. May be discharged outside the container. In that case, the processes from the third step onward are all wasted work. Moreover, in the finally refined state, it is not even visually confirmed, and there is a problem in that the notice is delayed. In order to prevent the inconvenience, it is conceivable to store the passing liquid in the second step to the end as a second best measure and start again from the second step. However, this is also a great waste. Therefore, an object of the present invention is to make it possible to confirm whether or not the oligonucleotide is adsorbed and retained on the carrier in the container by a simple method but surely before moving to the third step through the second step, Accordingly, it is an object of the present invention to provide a method for treating synthetic DNA which can eliminate the waste of conventional treatment operations.
【0004】[0004]
【課題を解決するための手段】本発明に係るDNAの処
理方法は、次の第1工程ないし第6工程からなる。 第1工程 合成DNAにアンモニア水を加えて、レジン
から「保護されたオリゴヌクレオチド」を切り離す。 第2工程 脱保護されたDNA溶液を水で希釈して、こ
の希釈液を多孔性の担体が多数入った容器内に通し、該
担体にオリゴヌクレオチドを吸着保持させる。この際
に、前記容器内の担体に対するオリゴヌクレオチドの吸
着量を紫外可視分光光度計で定量分析する。 第3工程 前記容器内に洗浄液を通して不純物を除去す
る。 第4工程 前記容器内にTFA(トリフルオロ酢酸)等
の酸性液を通してオリゴヌクレオチドのDMT基を外
す。 第5工程 前記容器内に洗浄水を通して前記酸性液を除
去する。 第6工程 前記容器にアセトニトリル又はエタノールな
どの有機溶媒液を通し、該容器内の前記担体からオリゴ
ヌクレオチドを溶出させて回収する。又は、先の第2工
程において、前記容器内の担体に対するオリゴヌクレオ
チドの吸着量を検出するに代えて、該容器から出た通過
液中におけるオリゴヌクレオチドの含有量を紫外可視分
光光度計で定量分析する。更に具体的には、第6工程を
経て得た溶出液から有機溶媒を蒸発させたのち、高速液
体クロマトグラフィにかけて精製する。又は、第6工程
を経て得た溶出液に水を加えて希釈したのち、この希釈
溶出液を高速液体クロマトグラフィにかけて精製する。The method for treating DNA according to the present invention comprises the following first to sixth steps. First Step Ammonia water is added to the synthetic DNA to separate the "protected oligonucleotide" from the resin. Second step The deprotected DNA solution is diluted with water, and the diluted solution is passed through a container containing a large number of porous carriers to adsorb and hold the oligonucleotide on the carriers. At this time, the amount of the oligonucleotide adsorbed on the carrier in the container is quantitatively analyzed by an ultraviolet-visible spectrophotometer. Third Step Impurities are removed by passing a cleaning liquid into the container. Fourth Step An acidic liquid such as TFA (trifluoroacetic acid) is passed through the container to remove the DMT group of the oligonucleotide. Fifth step: The washing liquid is passed through the container to remove the acidic liquid. Sixth Step An organic solvent solution such as acetonitrile or ethanol is passed through the container, and the oligonucleotide is eluted from the carrier in the container and collected. Alternatively, in the second step, instead of detecting the amount of the oligonucleotide adsorbed to the carrier in the container, the content of the oligonucleotide in the passage solution discharged from the container is quantitatively analyzed by an ultraviolet-visible spectrophotometer. To do. More specifically, after evaporating the organic solvent from the eluate obtained through the sixth step, purification is performed by high performance liquid chromatography. Alternatively, water is added to the eluate obtained through the sixth step to dilute it, and the diluted eluate is purified by high performance liquid chromatography.
【0005】[0005]
【作用】第2工程において、容器内の担体に対するオリ
ゴヌクレオチドの吸着量は、公知の紫外可視分光光度計
で定量分析するので、この段階で該担体にオリゴヌクレ
オチドが吸着保持されていれば、そのまま第3工程以下
の手順に入る。同じ第2工程において、前記容器から出
た通過液中におけるオリゴヌクレオチドの含有量を可視
分光光度計で定量分析することにより、この通過液にオ
リゴヌクレオチドが混入されておらず、前記担体に必要
かつ十分のオリゴヌクレオチドが吸着保持されているこ
とを確認できれば、この場合も第3工程以下の手順に入
る。いずれにせよ、前記容器内の担体に所定量のオリゴ
ヌクレオチドが吸着保持されていないときは、前記通過
液を再び該容器内に通す作業を繰り返し、この第2工程
の中で担体にオリゴヌクレオチドを確実に吸着保持させ
る。In the second step, the amount of the oligonucleotide adsorbed on the carrier in the container is quantitatively analyzed by a known UV-visible spectrophotometer. Step 3 The following steps are entered. In the same second step, the content of the oligonucleotide in the passage solution discharged from the container was quantitatively analyzed by a visible spectrophotometer, whereby the passage solution was not contaminated with the oligonucleotide and was necessary for the carrier. If it can be confirmed that a sufficient amount of oligonucleotide is adsorbed and retained, the procedure from the third step onward is started also in this case. In any case, when a predetermined amount of the oligonucleotide is not adsorbed and held on the carrier in the container, the operation of passing the passing solution through the container again is repeated, and the oligonucleotide is added to the carrier in the second step. Make sure to hold it by suction.
【0006】[0006]
(実施例1) 第1工程 合成DNAに30%アンモニア水を加え、室
温で2時間を経てガラス、ポリエチレンなどのレジンか
ら「保護されたオリゴヌクレオチド」を切り離すととも
に、このとき保護基も外す。 第2工程 第1工程で脱保護されたDNA溶液に同一容
量の水を加えて希釈し、C18(炭素数18)の多孔性
の球状担体が多数収納された容器に該希釈液を通し、不
活性ガスで圧力をかけて「脱保護されたオリゴヌクレオ
チド」をのみ担体に吸着保持させる。このとき、容器内
の担体に対するオリゴヌクレオチドの吸着量を公知の紫
外可視分光光度計で定量分析し、担体にオリゴヌクレオ
チドが吸着保持されていることを確認する。このとき、
担体にオリゴヌクレオチドが必要かつ十分に吸着保持さ
れていないときは、前記容器からの通過液を改めて該容
器に通し直す。かくして担体に所定量のオリゴヌクレオ
チドが確実に吸着保持されていることをこの段階で確認
する。(Example 1) First step 30% aqueous ammonia is added to synthetic DNA, and the "protected oligonucleotide" is separated from the resin such as glass and polyethylene at room temperature for 2 hours, and at the same time, the protecting group is also removed. Second step The same volume of water is added to the DNA solution deprotected in the first step to dilute it, and the diluted solution is passed through a container containing a large number of porous C18 (carbon number 18) spherical carriers. Only the "deprotected oligonucleotide" is adsorbed and held on the carrier by applying pressure with an active gas. At this time, the amount of the oligonucleotide adsorbed to the carrier in the container is quantitatively analyzed by a known UV-visible spectrophotometer to confirm that the carrier adsorbs and holds the oligonucleotide. At this time,
When the oligonucleotide is not adsorbed and retained on the carrier in a necessary and sufficient manner, the passage liquid from the container is passed through the container again. Thus, it is confirmed at this stage that the predetermined amount of the oligonucleotide is surely adsorbed and held on the carrier.
【0007】第3工程 前記担体の入った前記容器内に
3%アンモニア水を繰り返して2回通し、担体にオリゴ
ヌクレオチドを残し、他の不純物を水洗い除去する。 第4工程 同じ容器内に2%TFA(トリフルオロ酢
酸)を通し、合成DNAのDMT基を外して溶出させ
る。 第5工程 同じ容器内に水を通し、前記TFAを水洗い
除去する。 第6工程 同じ容器内に有機溶媒液として20%アセト
ニトリルを通し、担体より目的のオリゴヌクレオチドを
該容器外に溶出させ、その溶出液を第2の容器に回収す
る。ここまでは自動化して処理する。 第7工程 次に、オリゴヌクレオチドの溶出液を凍結乾
燥し、前記有機溶媒を蒸発させる。 第8工程 最後に凍結乾燥して得たオリゴヌクレオチド
を高速液体クロマトグラフィにかけて最終精製する。Third step 3% ammonia water is repeatedly passed twice into the container containing the carrier to leave the oligonucleotide on the carrier, and other impurities are washed away. Step 4 2% TFA (trifluoroacetic acid) is passed through the same container to remove the DMT group of the synthetic DNA for elution. Fifth step Water is passed through the same container to wash and remove the TFA. Sixth step 20% acetonitrile as an organic solvent liquid is passed through the same container to elute the target oligonucleotide from the carrier out of the container, and the eluate is collected in a second container. Up to this point, processing is automated. Seventh Step Next, the eluate of the oligonucleotide is freeze-dried, and the organic solvent is evaporated. Eighth step Finally, the oligonucleotide obtained by freeze-drying is finally purified by high performance liquid chromatography.
【0008】(実施例2)実施例1の第2工程におい
て、担体が入った前記容器からの通過液を回収し、この
通過液中におけるオリゴヌクレオチドの含有量を紫外可
視分光光度計で定量分析し、通過液にオリゴヌクレオチ
ドが含有されていないこと、すなわち前記容器中の担体
にオリゴヌクレオチドが必要かつ十分に吸着保持されて
いることを確認したうえで、次の第3工程に移った。な
お、この場合も前記定量分析によって容器中の担体に所
定量のオリゴヌクレオチドが吸着保持されていないとき
は、前記通過液を改めて容器内に通し直す。それ以外は
実施例1と同様にした。(Example 2) In the second step of Example 1, the passing solution from the container containing the carrier was recovered, and the content of the oligonucleotide in the passing solution was quantitatively analyzed by an ultraviolet-visible spectrophotometer. Then, after confirming that the passing solution did not contain the oligonucleotide, that is, the oligonucleotide in the container was adsorbed and retained by the carrier in the necessary and sufficient manner, the process proceeded to the next third step. Also in this case, when the predetermined amount of the oligonucleotide is not adsorbed and held on the carrier in the container by the quantitative analysis, the passage liquid is re-passed into the container again. The other conditions were the same as in Example 1.
【0009】(実施例3)実施例1又は2において、そ
こでの第6工程を経て得たオリゴヌクレオチドの溶出液
に水を加えて希釈したのち、実施例1の第7工程を省略
して該希釈液を高速液体クロマトグラフィにかけて精製
した。Example 3 In Example 1 or 2, after water was added to the eluate of the oligonucleotide obtained through the 6th step to dilute it, the 7th step of Example 1 was omitted. The diluted solution was purified by high performance liquid chromatography.
【0010】[0010]
【発明の効果】かかる本発明によれば、第2工程におい
て容器内の担体にオリゴヌクレオチドが吸着保持されて
いることを紫外可視分光光度計で定量分析して事前に確
認したうえで第3工程に入れるので、その後の処理工程
に一切の無駄がなく全体として能率的である。しかも、
公知の紫外可視分光光度計を用いるだけであるから格別
のコストを掛けずに済み、確実にミスのない処理を行え
た。EFFECTS OF THE INVENTION According to the present invention, it is confirmed in advance that the oligonucleotide is adsorbed and held on the carrier in the container in the second step by quantitative analysis with an ultraviolet-visible spectrophotometer before the third step. Since it is put in the box, there is no waste in the subsequent processing steps and it is efficient as a whole. Moreover,
Since only a known UV-visible spectrophotometer is used, no special cost is required, and the processing can be surely performed without error.
Claims (4)
ジンから「保護されたオリゴヌクレオチド」を切り離す
第1工程と、 脱保護されたDNA溶液を水で希釈して、この希釈液を
多孔性の担体が多数入った容器内に通し、該担体にオリ
ゴヌクレオチドを吸着保持させる第2工程と、 前記容器内に洗浄液を通して不純物を除去する第3工程
と、 前記容器内に酸性液を通してオリゴヌクレオチドのDM
T基を外す第4工程と、 前記容器内に洗浄水を通して前記酸性液を除去する第5
工程と、 前記容器に有機溶媒液を通し、該容器内の前記担体から
オリゴヌクレオチドを溶出させて回収する第6工程とか
らなり、 第2工程において、前記容器内の担体に対するオリゴヌ
クレオチドの吸着量を紫外可視分光光度計で定量分析す
ることを特徴とする合成DNAの処理方法。1. A first step of adding ammonia water to the synthetic DNA to separate the "protected oligonucleotide" from the resin, and diluting the deprotected DNA solution with water to form a porous solution of the diluted solution. A second step of passing the carrier through a container containing a large number of carriers and adsorbing and holding the oligonucleotide on the carrier, a third process of passing a washing solution through the container to remove impurities, and an acidic solution passing through the container for DM of oligonucleotide
Fourth step of removing the T group, and fifth step of passing the washing water through the container to remove the acidic liquid
And a sixth step of passing an organic solvent solution through the container to elute and recover the oligonucleotide from the carrier in the container, and in the second step, the amount of the oligonucleotide adsorbed to the carrier in the container A method for treating synthetic DNA, which comprises quantitatively analyzing with a UV-visible spectrophotometer.
過液中におけるオリゴヌクレオチドの含有量を紫外可視
分光光度計で定量分析する合成DNAの処理方法。2. The method of treating synthetic DNA in the second step, which comprises quantitatively analyzing the content of the oligonucleotide in the flow-through solution discharged from the container with an ultraviolet-visible spectrophotometer.
を蒸発させたのち、高速液体クロマトグラフィにかけて
精製する合成DNAの処理方法。3. A method for treating synthetic DNA, which comprises evaporating an organic solvent from the eluate obtained through the sixth step and then purifying it by high performance liquid chromatography.
希釈したのち、この希釈溶出液を高速液体クロマトグラ
フィにかけて精製する合成DNAの処理方法。4. A method for treating synthetic DNA, which comprises diluting an eluate obtained through the sixth step by adding water, and purifying the diluted eluate by high performance liquid chromatography.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4185794A JPH07227284A (en) | 1994-02-15 | 1994-02-15 | Method for treating synthetic dna |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4185794A JPH07227284A (en) | 1994-02-15 | 1994-02-15 | Method for treating synthetic dna |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07227284A true JPH07227284A (en) | 1995-08-29 |
Family
ID=12619926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4185794A Pending JPH07227284A (en) | 1994-02-15 | 1994-02-15 | Method for treating synthetic dna |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07227284A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007094581A1 (en) * | 2006-02-14 | 2007-08-23 | Bioneer Corporation | Dried oligonucleotide composition and method of producing the same |
-
1994
- 1994-02-15 JP JP4185794A patent/JPH07227284A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007094581A1 (en) * | 2006-02-14 | 2007-08-23 | Bioneer Corporation | Dried oligonucleotide composition and method of producing the same |
KR100777249B1 (en) * | 2006-02-14 | 2007-11-28 | (주)바이오니아 | Dried Oligonucleotide Composition and Method of Producing the Same |
US9200027B2 (en) | 2006-02-14 | 2015-12-01 | Bioneer Corporation | Dried oligonucleotide composition and method of producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6342387B1 (en) | Method for isolating DNA | |
CN101871920A (en) | Multistage improvement column for quickly pre-processing and purifying polychlorinated biphenyl in biological sample | |
CN113219102A (en) | Method for measuring content of toxic substances and metabolites thereof in sewage | |
HU197926B (en) | Process for recovering glycopeptide antibiotics | |
EP0754083B1 (en) | Process for separating material from mixture using displacement chromatography | |
JPH07227284A (en) | Method for treating synthetic dna | |
US4267056A (en) | Sample preparation apparatus and process for the use thereof | |
WO2020127505A1 (en) | A method for removing nucleosomal contaminants from bioprocessing solutions | |
Fortis et al. | A new approach for the removal of protein impurities from purified biologicals using combinatorial solid‐phase ligand libraries | |
US20230151351A1 (en) | A method of single-stranded rna purification | |
Svensson et al. | Vancomycin‐based chiral stationary phases for micro‐column liquid chromatography | |
CN103816695B (en) | The solid phase extraction of phenols endocrine disruptors in a kind of sample | |
US10974168B2 (en) | Materials and methods for the selective recovery of monovalent products from aqueous solutions using continuous ion exchange | |
Gagnon et al. | The secret life of Protein A | |
JP2007155465A (en) | Analyzing method | |
RO110823B1 (en) | Amino oxides' separation process from watery solutions resulting from the cellulose working | |
US6479296B1 (en) | Solid phase precipitation and extraction | |
CN117705998A (en) | Novel EDURISP proteomics sample pretreatment method | |
US5009788A (en) | Method for removing organic and tungsten from sodium sulfate solution | |
JP2005283514A (en) | Method for purifying phosphorylated peptide originating in natural sample utilizing titania column | |
JP3079554B2 (en) | Synthetic DNA purification method | |
CN115407002A (en) | Purification and enrichment method for detecting plant endogenous small peptide hormone in plant material | |
HU213477B (en) | Process for preparing framycetin sulphate | |
CN112159806A (en) | Nucleic acid dissociation liquid and application thereof in nucleic acid extraction | |
JP2001278892A (en) | Method for separating and removing erythromycin f |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Effective date: 20040107 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A521 | Written amendment |
Effective date: 20040224 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
A131 | Notification of reasons for refusal |
Effective date: 20040317 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040707 |